Epidemiological evidence and molecular basis of interactions between HIV and JC virus

Journal of NeuroVirology

Volumn 7, Issue 4, 2001, Pages 329-338

  Berger, J R ^a   Chauhan, A ^a   Galey, D ^a   Nath, A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JC VIRUS; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN SECRETION; PROTEIN TRANSPORT; TRANSACTIVATION; VASCULAR ENDOTHELIUM; VIRUS INFECTION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINO ACID SEQUENCE; GENES, TAT; HIV; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MOLECULAR SEQUENCE DATA;

EID: 0034834036     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280152537193     Document Type: Article

References (89)

1. Identification of a novel domain of HIV tat involved in monocyte chemotaxis
2. Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes
3. Promyelinating Schwann cells express Tst-1/SCIP/Oct-6
4. Progressive multifocal leukoencephalopathy
5. Interaction of the human polyomavirus, JCV, with human B-lymphocytes
6. Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells
7. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS cohort study, 1985-1992
8. Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS
9. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases
10. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy
11. Progressive multifocal leukoencephalopathy
12. Cerebrovascular changes in the basal ganglia with HIV dementia
13. Progressive multifocal leukoencephalopathy in patients with HIV infection
14. Progressive multifocal leukoencephalopathy
15. HIV-1 tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycan through its basic region
16. The Tat protein of HIV-1 induces tumor necrosis factor-a production: Implications for HIV associated neurological diseases
17. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat
18. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein
19. Induction of monocyte chemotactic protein-1 HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
20. Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1
21. Infiltration of inflammatory cells through brain endothelium
22. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis
23. Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy
24. Immunopathogenesis
25. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
26. Release, uptake, and effects of extracellular human immunodeficiency virus type-1 Tat protein on cell growth and viral replication
27. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA
28. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989
29. Tat toxoid as a component of a preventive vaccine in seronegative subjects
30. Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients
31. Opportunistic infections in children following renal transplantation
32. Exogenous tat protein activates central nervous system-derived endothelial cells
33. Epidemiology of progressive multifocal leukoencephalopathy in the United States: Analysis of national mortality and AIDS surveillance data
34. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy
35. HIV-1 gp 120 modulates hypothalamic cytokine mRNAs in vivo: Implications to cytokine feedback systems
36. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors
37. Evidence that Par-4 participates in the pathogenesis of AIDS dementia
38. Progressive multifocal leukoencephalopathy: Clinical and radiographic features
39. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases
40. Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric, and fetal brains
41. Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland
42. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands
43. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
44. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells
45. Expression of the Tat protein of HIV 1 in human promonocytic U937 cells
46. Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV
47. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
48. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
49. Accuracy of death certificate completion
50. Detection of JC virus DNA in human tonsil tissue: Evidence for site of initial viral infection
51. HIV infection of human brain capillary endothelial cells: Implications for AIDS dementia
52. Transient Exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: A hit and run phenomenon
53. Role of viral proteins in neuropathogenesis of HIV infection with emphasis on Tat
54. Unraveling the neuroimmune mechanisms for the HIV-1 associated cognitive/motor complex
55. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain
56. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from Botswana
57. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis
58. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia
59. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain
60. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: Involvement of cytokines
61. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier
62. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor
63. Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines
64. The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus
65. Structure and expression of tat-,rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages
66. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96)
67. In vivo protein transduction: Delivery of a biologically active protein into the mouse
68. The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU domain protein Tst-1/Oct6/SCIP
69. Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center
70. JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy
71. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells
72. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion
73. Evidence of blood-brain barrier alteration and activation in HIV-1 gp 120 transgenic mice
74. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy
75. Association of JC virus large T antigen with myelin basic protein transcription factor (MEF-1/Puralpha) in hypomyelinated brains of mice transgenically expressing T antigen
76. Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: Evidence for association of Spl and Puralpha in brain
77. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine
78. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy
79. The epidemiology of human polyomaviruses
80. HIV-Tat induces MCP-1 mediated monocyte transmigration and upregulates CCR5 expression on human monocytes
81. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia
82. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp 120
83. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: Neuroimaging with clinical and pathologic correlation
84. Expression of regulatory and structural mRNA in the central nervous system
85. Traffic of hematogenous cells through the central nervous system
86. Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes
87. Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: Characterization of RNA-mediated protein-protein binding
88. Medical and surgical complications of renal transplantation: Diagnosis and management
89. Interaction of HIV-1 gp 120 molecule fragments with human monocytes: Different requirements for tumor necrosis factor-alpha and IL-6 production